Armata Pharmaceuticals Inc (ARMP) Live Share Price, Invest From India

Armata Pharmaceuticals Inc Stock Performance

as on December 9, 2025 at 1:36 am IST

Day's Low
Day's High
$5.49
Day's Price Range
$5.88
$5.65
2.83%
Downside
4.07%
Upside
52 Week's Low
52 Week's High
$0.9
52-Week Price Range
$16.34
$5.65
84.10%
Downside
189.20%
Upside

Armata Pharmaceuticals Inc share price movements today

Previous Close: $5.63
Open: $5.68
Volume: 202.6K
Day's Low - High: $5.49 - $5.88
52 Week Low - High: $0.9 - $16.34

Armata Pharmaceuticals Inc Historical Returns

1 Month Return: -2.6 %
3 Month Return: + 99.65 %
1 Year Return: + 157.08 %
3 Year Return: + 193.23 %
5 Year Return: + 79.01 %

Armata Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Armata Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$205.0M

EPS (TTM)

-1.54

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-31.9M

Revenue (TTM)

5.1M

Profit Margin

0.00%

Return On Equity TTM

-3439.35%

Armata Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Armata Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Armata Pharmaceuticals Inc	BUY	$205.0M	79.01%	NA	0.00%
Insmed Incorporated	BUY	$43.5B	418.42%	-16.34	-264.83%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	257.77%	1431.62	1.36%
Vertex Pharmaceuticals Incorporated	BUY	$116.8B	98.18%	32.05	31.35%
Regeneron Pharmaceuticals, Inc.	BUY	$76.1B	44.5%	17.21	32.13%

Stock Returns calculator for Armata Pharmaceuticals Inc Stock including INR - Dollar returns

The Armata Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Armata Pharmaceuticals Inc investment value today

Current value as on today

₹2,64,130

Returns

₹1,64,130

(+164.13%)

Returns from Armata Pharmaceuticals Inc Stock

₹1,57,991 (+157.99%)

Dollar Returns*

₹6,139 (+6.14%)

Analyst Recommendation on Armata Pharmaceuticals Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Armata Pharmaceuticals Inc. Average target price of $9

Armata Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Armata Pharmaceuticals Inc.

What analysts predicted

37.22%UPSIDE

Target Price

Current Price

$5.65

Analyzed by

8 Analysts

Target

$9.00

Armata Pharmaceuticals Inc target price $9, a slight upside of 37.22% compared to current price of $5.65. According to 8 analysts rating.

Armata Pharmaceuticals Inc Stock’s Investor Sentiment and Interest

Search interest for Armata Pharmaceuticals Inc Stock has decreased by -22% in the last 30 days, reflecting a downward trend in search activity.

Time period: November 9, 2025 to December 9, 2025

Change:-22% versus previous 30 day period

Armata Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	0	1	1	0	-	2	1	0	2	1
Gross Profit	0	1	1	0	0	2	0	0	1	0
Operating Income	-9	-10	-9	-10	-11	-9	-10	-8	-6	-7
EBITDA	-3	-29	-18	-22	12	-2	6	-2	-12	-21
Interest Expense	-	1	1	1	2	2	3	3	3	4
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-3	-31	-19	-25	8	-5	2	-6	-16	-26
Income Tax Expense	-6	-14	17	0	-	-	0	-	-	-
Net Income	-3	-31	-19	-25	8	-5	2	-6	-16	-26
Net Profit Margin	-361.94%	-2543.76%	-1298.89%	-2590.17%	0.00%	-184.36%	210.53%	-1330.14%	-751.27%	-2301.55%

Armata Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	0	0	-	0	0	4	5	4	5
Gross Profit	0	0	0	-1	-1	-13	-15	-29	3	-29
Operating Income	-10	-23	-16	-12	-19	-21	-23	-36	-40	-42
EBITDA	-10	-13	-9	-9	-17	-20	-21	-36	-65	-41
Interest Expense	-	-	-	-	0	0	0	0	2	10
Depreciation	-	-	0	0	1	1	1	0	0	1
Income Before Tax	0	-19	-14	-16	-19	-22	-23	-36	-69	-18
Income Tax Expense	0	0	-1	0	0	0	0	0	-	-
Net Income	0	-18	-12	-12	-19	-22	-23	-36	-69	-18
Net Profit Margin	-108.63%	-7245.38%	-11163.48%	0.00%	-62835.48%	-2695.14%	-517.55%	-670.24%	-1524.51%	-365.60%

Armata Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-31	-19	-25	8	-5	2	-6	-16	-26
Operating Cash Flow	-9	-8	-10	-10	-8	-7	-7	-7	-4
Investing Cash Flow	-3	-2	0	-1	0	0	0	0	0
Financing Cash Flow	24	0	34	0	0	-	9	-	14
Change in Cash	11	-10	24	-11	-9	-7	2	-7	10

Armata Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-18	-12	-12	-19	-22	-23	-36	-69	-18
Operating Cash Flow	-10	-9	-9	-15	-18	-23	-32	-47	-37
Investing Cash Flow	0	0	0	2	0	-1	-2	-8	-1
Financing Cash Flow	7	8	12	8	23	25	44	53	34
Change in Cash	-3	0	3	-3	4	0	4	-1	-4

Insights on Armata Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 170.6% return, outperforming this stock by 13.5%
NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 995.0% return, outperforming this stock by 801.8%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 2.16M → 1.15M (in $), with an average decrease of 46.6% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 4 quarters, 2.6M → -26.67M (in $), with an average decrease of 188.1% per quarter
NEGATIVE IMPACT
Price Dip
In the last 7 days, ARMP stock has moved down by -16.8%

About Armata Pharmaceuticals Inc

c3 jian is a well-capitalized, private, los angeles based biotechnology company advancing novel compounds that target unmet medical/dental needs related primarily to oral healthcare. the company's lead compound is a unique peptide drug against dental caries (i.e. tooth decay). the company’s lead compound started fda-regulated phase ii human clinical trials in early 2014. c3 jian's platform technology has also yielded peptides that can affect calcification processes, including not only tooth sensitivity but possibly hair and nail growth as well. the company has recently moved its operations to a new facility in marina del rey. the company was founded based on technology created in the laboratory of dr. wenyuan shi, chair of the department of oral biology at the university of california, los angeles school of dentistry. for more information about the company and to explore career opportunities at c3 jian please visit our webpage at www.c3-jian.com

Organisation	Armata Pharmaceuticals Inc
Headquarters	5005 McConnell Avenue, Los Angeles, CA, United States, 90066
Industry	Biotechnology
CEO	Dr. Deborah L. Birx M.D.
E-voting on shares	Click here to vote

Key Management of Armata Pharmaceuticals Inc

Name	Title
Mr. David D. House	Senior VP of Finance & Principal Financial Officer
Dr. Pierre Kyme Ph.D.	Chief Business Officer
Mr. Peter Hubbard	Vice President of Operations
Ms. Bani Tchekanova Ph.D.	Head of Regulatory Strategy & Operations
Dr. Deborah L. Birx M.D.	CEO & Director

FAQs

What is Armata Pharmaceuticals Inc share price today?

Armata Pharmaceuticals Inc share price today is $5.65 as on December 9, 2025 at 1:36 am IST. Armata Pharmaceuticals Inc share today touched a day high of $5.88 and a low of $5.49.

What is the 52 week high and 52 week low for Armata Pharmaceuticals Inc share?

Armata Pharmaceuticals Inc share touched a 52 week high of $16.34 on October 22, 2025 and a 52 week low of $0.9 on April 9, 2025. Armata Pharmaceuticals Inc stock price today i.e. December 9, 2025 at 1:36 am IST is trending at $5.65,which is 65.42% down from its 52 week high and 529.11% up from its 52 week low.

What is Armata Pharmaceuticals Inc's market capitalisation today?

Armata Pharmaceuticals Inc market capitalisation is $0.00T as on December 9, 2025 at 1:36 am IST.

How to invest in Armata Pharmaceuticals Inc Stock (ARMP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Armata Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Armata Pharmaceuticals Inc Shares that will get you 0.2655 shares as per Armata Pharmaceuticals Inc share price of $5.65 per share as on December 9, 2025 at 1:36 am IST.

What is the minimum amount required to buy Armata Pharmaceuticals Inc Stock (ARMP) from India?

Indian investors can start investing in Armata Pharmaceuticals Inc (ARMP) shares with as little as ₹90.066 or $1 (as of December 9, 2025 at 1:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹900.66 in Armata Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on December 9, 2025 at 1:40 am IST). Based on Armata Pharmaceuticals Inc share’s latest price of $5.65 as on December 9, 2025 at 1:36 am IST, you will get 1.7699 shares of Armata Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Armata Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Armata Pharmaceuticals Inc stock has given 79.01% share price returns and 22% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?